{"id":349778,"date":"2025-08-25T18:21:04","date_gmt":"2025-08-25T18:21:04","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-sanofi\/"},"modified":"2025-08-25T18:21:04","modified_gmt":"2025-08-25T18:21:04","slug":"how-to-buy-sanofi","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/","title":{"rendered":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131"},"description":"2025 piyasa ko\u015fullar\u0131 i\u00e7in g\u00fcncel fiyat analizi, b\u00fcy\u00fcme f\u0131rsatlar\u0131 ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Sanofi (SNY) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"2025 piyasa ko\u015fullar\u0131 i\u00e7in g\u00fcncel fiyat analizi, b\u00fcy\u00fcme f\u0131rsatlar\u0131 ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Sanofi (SNY) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Portf\u00f6y\u00fcn\u00fcze bir ila\u00e7 devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Sanofi (SNY), a\u015f\u0131lar, nadir hastal\u0131klar ve imm\u00fcnoloji tedavilerini kapsayan \u00e7e\u015fitli \u00fcr\u00fcn portf\u00f6y\u00fc ile Avrupa'n\u0131n en b\u00fcy\u00fck sa\u011fl\u0131k \u015firketlerinden biridir. 2025'teki stratejik sat\u0131n almalar ve g\u00fc\u00e7l\u00fc \u00fcr\u00fcn geli\u015ftirme hatt\u0131 ile bu hisse, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunmaktad\u0131r.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze bir ila\u00e7 devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Sanofi (SNY), a\u015f\u0131lar, nadir hastal\u0131klar ve imm\u00fcnoloji tedavilerini kapsayan \u00e7e\u015fitli \u00fcr\u00fcn portf\u00f6y\u00fc ile Avrupa'n\u0131n en b\u00fcy\u00fck sa\u011fl\u0131k \u015firketlerinden biridir. 2025'teki stratejik sat\u0131n almalar ve g\u00fc\u00e7l\u00fc \u00fcr\u00fcn geli\u015ftirme hatt\u0131 ile bu hisse, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunmaktad\u0131r."},"body_html":"<h2>\ud83d\udcc8 Sanofi Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Sanofi (SNY), NASDAQ borsas\u0131nda <strong>51,08 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. \u015eirket, yakla\u015f\u0131k 126 milyar $ piyasa de\u011feri ile Avrupa'n\u0131n en b\u00fcy\u00fck ila\u00e7 \u015firketlerinden biri olarak sa\u011flam bir piyasa konumunu korumaktad\u0131r.<\/p> <p><strong>Takviminize not edin: 24 Ekim 2025<\/strong>, Sanofi'nin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 kritik tarihtir. Tarihsel olarak, bu a\u00e7\u0131klamalar hisse fiyat\u0131nda \u00f6nemli hareketlere neden olmu\u015ftur. Yakla\u015fan kazan\u00e7lar, \u015firketin son stratejik de\u011fi\u015fiklikleri ve sat\u0131n almalar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u00f6zellikle \u00f6nemli olacakt\u0131r.<\/p> <h3>Son Kazan\u00e7lar\u0131n Etki Analizi<\/h3> <p>Tarihsel desenlere bak\u0131ld\u0131\u011f\u0131nda, Sanofi hisseleri genellikle kazan\u00e7 a\u00e7\u0131klamalar\u0131 etraf\u0131nda %3-8 aras\u0131nda fiyat hareketleri ya\u015famaktad\u0131r. 31 Temmuz 2025'te a\u00e7\u0131klanan en son 2. \u00e7eyrek raporu kar\u0131\u015f\u0131k sonu\u00e7lar g\u00f6stermi\u015ftir - 11,34 milyar $ gelir beklentileri a\u015farken, 0,90 $ hisse ba\u015f\u0131 kazan\u00e7 (EPS) 0,96 $ konsens\u00fcs tahmininin alt\u0131nda kalm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SNY\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>).<\/p> <p>Desen, pozitif s\u00fcrprizlerin negatif s\u00fcrprizlere k\u0131yasla daha g\u00fc\u00e7l\u00fc y\u00fckseli\u015fler tetikledi\u011fini, bu da yat\u0131r\u0131mc\u0131lar\u0131n \u015firketin uzun vadeli stratejisine olan g\u00fcvenini g\u00f6stermektedir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Performans\u0131 ve Trend Analizi<\/h2> <p>Sanofi hisseleri, son alt\u0131 ayda piyasa dalgalanmalar\u0131na kar\u015f\u0131 diren\u00e7 g\u00f6stermi\u015ftir:<\/p> <p><strong>Ocak-Mart 2025<\/strong>: Yakla\u015f\u0131k 47,95 $ seviyesinden 52,60 $ seviyesine kadar istikrarl\u0131 bir y\u00fckseli\u015f trendi, 2024 4. \u00e7eyrek olumlu sonu\u00e7lar\u0131 ve stratejik sat\u0131n alma duyurular\u0131 ile desteklenmi\u015ftir.<\/p> <p><strong>Nisan-Haziran 2025<\/strong>: \u0130la\u00e7 d\u00fczenlemeleri ve fiyat bask\u0131lar\u0131yla ilgili genel piyasa endi\u015feleri nedeniyle yakla\u015f\u0131k 47,65 $ seviyesine orta d\u00fczeyde bir d\u00fczeltme ya\u015fanm\u0131\u015ft\u0131r.<\/p> <p><strong>Temmuz-A\u011fustos 2025<\/strong>: Beklenenden iyi gelen 2. \u00e7eyrek gelirleri ve iyimser rehberlik g\u00fcncellemeleriyle desteklenen g\u00fc\u00e7l\u00fc bir toparlanma ile mevcut 51,08 $ seviyelerine ula\u015f\u0131lm\u0131\u015ft\u0131r.<\/p> <p>Genel 6 ayl\u0131k performans <strong>%+6,5 kazan\u00e7<\/strong> g\u00f6stererek zorlu d\u00fczenleyici ortamda bir\u00e7ok ila\u00e7 sekt\u00f6r\u00fcndeki rakibini geride b\u0131rakm\u0131\u015ft\u0131r. Hisse, 47-48 $ seviyelerinde destek bulurken 52 $ direncini k\u0131rma yetene\u011fi g\u00f6stermi\u015ftir.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>K\u0131sa Vadeli Projeksiyonlar (2025)<\/h3> <p>Analistler, Sanofi'nin 2025 sonuna kadar <strong>55-58 $<\/strong> seviyelerine ula\u015fmas\u0131n\u0131 beklemekte olup, bu mevcut seviyelerden %8-14 aras\u0131nda potansiyel y\u00fckseli\u015f anlam\u0131na gelmektedir. Bu iyimserlik, \u015firketin sat\u0131\u015f rehberli\u011fini y\u00fcksek tek haneli b\u00fcy\u00fcmeye ve beklenen d\u00fc\u015f\u00fck \u00e7ift haneli EPS b\u00fcy\u00fcmesine y\u00fckseltmesinden kaynaklanmaktad\u0131r (<a href=\"https:\/\/stockscan.io\/stocks\/SNY\/forecast\">StockScan Tahmini<\/a>).<\/p> <h3>Orta Vadeli G\u00f6r\u00fcn\u00fcm (2026-2028)<\/h3> <p>2026 y\u0131l\u0131na kadar, yeni piyasaya s\u00fcr\u00fclen \u00fcr\u00fcnlerin pazar pay\u0131 kazanmas\u0131 ve sat\u0131n almalar\u0131n gelir b\u00fcy\u00fcmesine katk\u0131da bulunmas\u0131yla <strong>60-65 $<\/strong> fiyat hedefi \u00fczerinde konsens\u00fcs tahminleri bulunmaktad\u0131r. 2028 projeksiyonu, ba\u015far\u0131l\u0131 \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri ve pazar geni\u015flemesi varsay\u0131larak <strong>68-75 $<\/strong> aral\u0131\u011f\u0131ndad\u0131r.<\/p> <h3>Uzun Vadeli Vizyon (2030)<\/h3> <p>Uzun vadeli analistler, demografik e\u011filimlerin sa\u011fl\u0131k harcamalar\u0131n\u0131 desteklemesi, geli\u015fmekte olan pazar b\u00fcy\u00fcmesi ve mevcut Ar-Ge yat\u0131r\u0131mlar\u0131ndan potansiyel \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler sayesinde Sanofi'nin 2030 y\u0131l\u0131nda <strong>85-95 $<\/strong> seviyelerine ula\u015fmas\u0131n\u0131 \u00f6ng\u00f6rmektedir.<\/p> <p><strong>Sonu\u00e7: G\u00dc\u00c7L\u00dc AL<\/strong> - Makul de\u011ferleme (F\/K 12,34), temett\u00fc getirisi deste\u011fi ve \u00e7oklu b\u00fcy\u00fcme kataliz\u00f6rlerinin birle\u015fimi, SNY'yi hem gelir hem de b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in cazip k\u0131lmaktad\u0131r.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici Bask\u0131lar<\/strong>: ABD Enflasyon Azaltma Yasas\u0131, 2039 y\u0131l\u0131na kadar ila\u00e7 gelirlerini %31 oran\u0131nda azaltabilir (<a href=\"https:\/\/www.zs.com\/insights\/pharmaceutical-trends-2025-outlook-ai-suppchain-and-beyond\">ZS Associates Raporu<\/a>)<\/li> <li><strong>Patent S\u00fcrelerinin Dolmas\u0131<\/strong>: \u00c7o\u011fu ila\u00e7 \u015firketinde oldu\u011fu gibi, Sanofi de \u00f6nemli patentlerin sona ermesiyle jenerik rekabetle kar\u015f\u0131 kar\u015f\u0131yad\u0131r<\/li> <li><strong>\u00c7in Pazar\u0131ndaki Zorluklar<\/strong>: Yo\u011fun yerel rekabet ve d\u00fczenleyici de\u011fi\u015fiklikler nedeniyle PCSK9 inhibit\u00f6r\u00fc pazar\u0131ndan \u00e7\u0131k\u0131\u015f<\/li> <li><strong>Tedarik Zinciri K\u0131r\u0131lganl\u0131klar\u0131<\/strong>: API tedariki ve \u00fcretim maliyetlerini etkileyen jeopolitik gerilimler<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>\u00dcr\u00fcn Hatt\u0131 Ba\u015far\u0131s\u0131<\/strong>: Dokuz yeni ila\u00e7 y\u0131ll\u0131k bazda %47,3 b\u00fcy\u00fcme g\u00f6sterdi<\/li> <li><strong>Dupixent G\u00fcc\u00fc<\/strong>: Amiral gemisi \u00fcr\u00fcn, lansmandan sonra sekiz y\u0131l i\u00e7inde %20'den fazla b\u00fcy\u00fcme g\u00f6steriyor<\/li> <li><strong>Stratejik Sat\u0131n Almalar<\/strong>: Vigil Neuroscience (470 milyon $) ve Blueprint Medicines, n\u00f6roloji ve imm\u00fcnoloji portf\u00f6ylerini g\u00fc\u00e7lendiriyor<\/li> <li><strong>Rehberlik G\u00fcncellemesi<\/strong>: Sat\u0131\u015f rehberli\u011fi, aral\u0131\u011f\u0131n \u00fcst s\u0131n\u0131r\u0131nda y\u00fcksek tek haneli b\u00fcy\u00fcmeye y\u00fckseltildi<\/li> <li><strong>Mali Disiplin<\/strong>: 5 milyar \u20ac de\u011ferindeki hisse geri al\u0131m program\u0131n\u0131n %80'i tamamland\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'undan fazlas\u0131n\u0131 tek bir hisseye, SNY dahil, ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in tek seferde b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 48 $ (destek) ve 52 $ (diren\u00e7) seviyelerini izleyin<\/li> <li><strong>Sekt\u00f6rler aras\u0131nda \u00e7e\u015fitlendirin<\/strong>: D\u00fczenleyici riskleri y\u00f6netmek i\u00e7in ila\u00e7 sekt\u00f6r\u00fcndeki pozisyonunuzu di\u011fer sekt\u00f6rlerle dengeleyin<\/li> <\/ol> <p><em>Mizahi deneyimli t\u00fcccar g\u00f6r\u00fc\u015f\u00fc: \"\u0130la\u00e7 hisseleriyle ticaret yapmak fl\u00f6rt etmek gibidir - bazen harika kimya yakalars\u0131n\u0131z, bazen yan etkilerle kar\u015f\u0131la\u015f\u0131rs\u0131n\u0131z. Taahh\u00fctte bulunmadan \u00f6nce her zaman prospekt\u00fcs\u00fc okuyun!\"<\/em><\/p> <h2>\u2705 Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform, hisse ticareti i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131za para yat\u0131r\u0131n<\/td><td>Banka transferi, kredi kart\u0131 veya di\u011fer \u00f6deme y\u00f6ntemleriyle fon aktar\u0131m\u0131 yap\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Sipari\u015f vermeden \u00f6nce SNY'nin ger\u00e7ek zamanl\u0131 fiyat\u0131n\u0131 ve son haberleri kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015finizi verin<\/td><td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonunuzu izleyin<\/td><td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n ve \u015firket haberlerini d\u00fczenli takip edin<\/td><\/tr> <tr><td>7<\/td><td>Temett\u00fc yeniden yat\u0131r\u0131m\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td><td>SNY, temett\u00fcleri otomatik olarak yeniden yat\u0131rma imkan\u0131 sunar<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, Sanofi hisseleri ticareti konusunda birka\u00e7 avantaj sunmaktad\u0131r:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test etme imkan\u0131 sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>, tek bir belge ile an\u0131nda ticaret eri\u015fimi sunar. <strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri bulunmakta olup, yat\u0131r\u0131mc\u0131lara fon y\u00f6netiminde esneklik sa\u011flar.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, Sanofi gibi k\u00f6kl\u00fc \u015firketlerde pozisyon olu\u015fturmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir ve piyasa dinamiklerini pratik deneyimle \u00f6\u011frenmelerine olanak tan\u0131r.<\/p> <h2>\ud83c\udf0d 2025'te Sanofi: Sa\u011fl\u0131kta Yenilik Lideri<\/h2> <p>Sanofi, \u00f6zellikle imm\u00fcnoloji, a\u015f\u0131lar ve nadir hastal\u0131klarda g\u00fc\u00e7l\u00fc olan k\u00fcresel bir sa\u011fl\u0131k lideridir. \u015eirketin stratejik oda\u011f\u0131, tek seferlik b\u00fcy\u00fck ba\u015far\u0131lar pe\u015finde ko\u015fmak yerine franchise seviyesinde i\u015f kollar\u0131 in\u015fa etmeye kaym\u0131\u015ft\u0131r.<\/p> <p>Son geli\u015fmeler aras\u0131nda, t\u00fcketici sa\u011fl\u0131\u011f\u0131 biriminin Opella i\u015flemiyle ba\u015far\u0131l\u0131 bir \u015fekilde ayr\u0131lmas\u0131 yer almakta olup, bu da daha odaklanm\u0131\u015f bir ila\u00e7 \u015firketi yaratm\u0131\u015ft\u0131r. \u00dcr\u00fcn hatt\u0131nda yakla\u015f\u0131k 30'u Faz 3 veya kay\u0131t a\u015famas\u0131nda olmak \u00fczere 82 klinik a\u015fama projesi bulunmaktad\u0131r (<a href=\"https:\/\/www.labiotech.eu\/in-depth\/sanofi-pipeline-2025\/\">Labiotech \u00dcr\u00fcn Hatt\u0131 Analizi<\/a>).<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Sanofi, TIME dergisi taraf\u0131ndan d\u00fcnyan\u0131n en s\u00fcrd\u00fcr\u00fclebilir onuncu \u015firketi ve \u0130la\u00e7 &amp; Biyoteknoloji sekt\u00f6r\u00fcnde birinci olarak s\u0131ralanm\u0131\u015f, \u00e7evresel ve sosyal sorumlulu\u011fa ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 ve t\u0131bbi yenili\u011fi te\u015fvik etme kararl\u0131l\u0131\u011f\u0131n\u0131 vurgulam\u0131\u015ft\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Sanofi Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Sanofi (SNY), NASDAQ borsas\u0131nda <strong>51,08 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. \u015eirket, yakla\u015f\u0131k 126 milyar $ piyasa de\u011feri ile Avrupa&#8217;n\u0131n en b\u00fcy\u00fck ila\u00e7 \u015firketlerinden biri olarak sa\u011flam bir piyasa konumunu korumaktad\u0131r.<\/p>\n<p><strong>Takviminize not edin: 24 Ekim 2025<\/strong>, Sanofi&#8217;nin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 kritik tarihtir. Tarihsel olarak, bu a\u00e7\u0131klamalar hisse fiyat\u0131nda \u00f6nemli hareketlere neden olmu\u015ftur. Yakla\u015fan kazan\u00e7lar, \u015firketin son stratejik de\u011fi\u015fiklikleri ve sat\u0131n almalar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u00f6zellikle \u00f6nemli olacakt\u0131r.<\/p>\n<h3>Son Kazan\u00e7lar\u0131n Etki Analizi<\/h3>\n<p>Tarihsel desenlere bak\u0131ld\u0131\u011f\u0131nda, Sanofi hisseleri genellikle kazan\u00e7 a\u00e7\u0131klamalar\u0131 etraf\u0131nda %3-8 aras\u0131nda fiyat hareketleri ya\u015famaktad\u0131r. 31 Temmuz 2025&#8217;te a\u00e7\u0131klanan en son 2. \u00e7eyrek raporu kar\u0131\u015f\u0131k sonu\u00e7lar g\u00f6stermi\u015ftir &#8211; 11,34 milyar $ gelir beklentileri a\u015farken, 0,90 $ hisse ba\u015f\u0131 kazan\u00e7 (EPS) 0,96 $ konsens\u00fcs tahmininin alt\u0131nda kalm\u0131\u015ft\u0131r (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SNY\/earnings\/\">MarketBeat Kazan\u00e7 Verileri<\/a>).<\/p>\n<p>Desen, pozitif s\u00fcrprizlerin negatif s\u00fcrprizlere k\u0131yasla daha g\u00fc\u00e7l\u00fc y\u00fckseli\u015fler tetikledi\u011fini, bu da yat\u0131r\u0131mc\u0131lar\u0131n \u015firketin uzun vadeli stratejisine olan g\u00fcvenini g\u00f6stermektedir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Performans\u0131 ve Trend Analizi<\/h2>\n<p>Sanofi hisseleri, son alt\u0131 ayda piyasa dalgalanmalar\u0131na kar\u015f\u0131 diren\u00e7 g\u00f6stermi\u015ftir:<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: Yakla\u015f\u0131k 47,95 $ seviyesinden 52,60 $ seviyesine kadar istikrarl\u0131 bir y\u00fckseli\u015f trendi, 2024 4. \u00e7eyrek olumlu sonu\u00e7lar\u0131 ve stratejik sat\u0131n alma duyurular\u0131 ile desteklenmi\u015ftir.<\/p>\n<p><strong>Nisan-Haziran 2025<\/strong>: \u0130la\u00e7 d\u00fczenlemeleri ve fiyat bask\u0131lar\u0131yla ilgili genel piyasa endi\u015feleri nedeniyle yakla\u015f\u0131k 47,65 $ seviyesine orta d\u00fczeyde bir d\u00fczeltme ya\u015fanm\u0131\u015ft\u0131r.<\/p>\n<p><strong>Temmuz-A\u011fustos 2025<\/strong>: Beklenenden iyi gelen 2. \u00e7eyrek gelirleri ve iyimser rehberlik g\u00fcncellemeleriyle desteklenen g\u00fc\u00e7l\u00fc bir toparlanma ile mevcut 51,08 $ seviyelerine ula\u015f\u0131lm\u0131\u015ft\u0131r.<\/p>\n<p>Genel 6 ayl\u0131k performans <strong>%+6,5 kazan\u00e7<\/strong> g\u00f6stererek zorlu d\u00fczenleyici ortamda bir\u00e7ok ila\u00e7 sekt\u00f6r\u00fcndeki rakibini geride b\u0131rakm\u0131\u015ft\u0131r. Hisse, 47-48 $ seviyelerinde destek bulurken 52 $ direncini k\u0131rma yetene\u011fi g\u00f6stermi\u015ftir.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>K\u0131sa Vadeli Projeksiyonlar (2025)<\/h3>\n<p>Analistler, Sanofi&#8217;nin 2025 sonuna kadar <strong>55-58 $<\/strong> seviyelerine ula\u015fmas\u0131n\u0131 beklemekte olup, bu mevcut seviyelerden %8-14 aras\u0131nda potansiyel y\u00fckseli\u015f anlam\u0131na gelmektedir. Bu iyimserlik, \u015firketin sat\u0131\u015f rehberli\u011fini y\u00fcksek tek haneli b\u00fcy\u00fcmeye ve beklenen d\u00fc\u015f\u00fck \u00e7ift haneli EPS b\u00fcy\u00fcmesine y\u00fckseltmesinden kaynaklanmaktad\u0131r (<a href=\"https:\/\/stockscan.io\/stocks\/SNY\/forecast\">StockScan Tahmini<\/a>).<\/p>\n<h3>Orta Vadeli G\u00f6r\u00fcn\u00fcm (2026-2028)<\/h3>\n<p>2026 y\u0131l\u0131na kadar, yeni piyasaya s\u00fcr\u00fclen \u00fcr\u00fcnlerin pazar pay\u0131 kazanmas\u0131 ve sat\u0131n almalar\u0131n gelir b\u00fcy\u00fcmesine katk\u0131da bulunmas\u0131yla <strong>60-65 $<\/strong> fiyat hedefi \u00fczerinde konsens\u00fcs tahminleri bulunmaktad\u0131r. 2028 projeksiyonu, ba\u015far\u0131l\u0131 \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri ve pazar geni\u015flemesi varsay\u0131larak <strong>68-75 $<\/strong> aral\u0131\u011f\u0131ndad\u0131r.<\/p>\n<h3>Uzun Vadeli Vizyon (2030)<\/h3>\n<p>Uzun vadeli analistler, demografik e\u011filimlerin sa\u011fl\u0131k harcamalar\u0131n\u0131 desteklemesi, geli\u015fmekte olan pazar b\u00fcy\u00fcmesi ve mevcut Ar-Ge yat\u0131r\u0131mlar\u0131ndan potansiyel \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler sayesinde Sanofi&#8217;nin 2030 y\u0131l\u0131nda <strong>85-95 $<\/strong> seviyelerine ula\u015fmas\u0131n\u0131 \u00f6ng\u00f6rmektedir.<\/p>\n<p><strong>Sonu\u00e7: G\u00dc\u00c7L\u00dc AL<\/strong> &#8211; Makul de\u011ferleme (F\/K 12,34), temett\u00fc getirisi deste\u011fi ve \u00e7oklu b\u00fcy\u00fcme kataliz\u00f6rlerinin birle\u015fimi, SNY&#8217;yi hem gelir hem de b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in cazip k\u0131lmaktad\u0131r.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici Bask\u0131lar<\/strong>: ABD Enflasyon Azaltma Yasas\u0131, 2039 y\u0131l\u0131na kadar ila\u00e7 gelirlerini %31 oran\u0131nda azaltabilir (<a href=\"https:\/\/www.zs.com\/insights\/pharmaceutical-trends-2025-outlook-ai-suppchain-and-beyond\">ZS Associates Raporu<\/a>)<\/li>\n<li><strong>Patent S\u00fcrelerinin Dolmas\u0131<\/strong>: \u00c7o\u011fu ila\u00e7 \u015firketinde oldu\u011fu gibi, Sanofi de \u00f6nemli patentlerin sona ermesiyle jenerik rekabetle kar\u015f\u0131 kar\u015f\u0131yad\u0131r<\/li>\n<li><strong>\u00c7in Pazar\u0131ndaki Zorluklar<\/strong>: Yo\u011fun yerel rekabet ve d\u00fczenleyici de\u011fi\u015fiklikler nedeniyle PCSK9 inhibit\u00f6r\u00fc pazar\u0131ndan \u00e7\u0131k\u0131\u015f<\/li>\n<li><strong>Tedarik Zinciri K\u0131r\u0131lganl\u0131klar\u0131<\/strong>: API tedariki ve \u00fcretim maliyetlerini etkileyen jeopolitik gerilimler<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>\u00dcr\u00fcn Hatt\u0131 Ba\u015far\u0131s\u0131<\/strong>: Dokuz yeni ila\u00e7 y\u0131ll\u0131k bazda %47,3 b\u00fcy\u00fcme g\u00f6sterdi<\/li>\n<li><strong>Dupixent G\u00fcc\u00fc<\/strong>: Amiral gemisi \u00fcr\u00fcn, lansmandan sonra sekiz y\u0131l i\u00e7inde %20&#8217;den fazla b\u00fcy\u00fcme g\u00f6steriyor<\/li>\n<li><strong>Stratejik Sat\u0131n Almalar<\/strong>: Vigil Neuroscience (470 milyon $) ve Blueprint Medicines, n\u00f6roloji ve imm\u00fcnoloji portf\u00f6ylerini g\u00fc\u00e7lendiriyor<\/li>\n<li><strong>Rehberlik G\u00fcncellemesi<\/strong>: Sat\u0131\u015f rehberli\u011fi, aral\u0131\u011f\u0131n \u00fcst s\u0131n\u0131r\u0131nda y\u00fcksek tek haneli b\u00fcy\u00fcmeye y\u00fckseltildi<\/li>\n<li><strong>Mali Disiplin<\/strong>: 5 milyar \u20ac de\u011ferindeki hisse geri al\u0131m program\u0131n\u0131n %80&#8217;i tamamland\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;undan fazlas\u0131n\u0131 tek bir hisseye, SNY dahil, ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in tek seferde b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 48 $ (destek) ve 52 $ (diren\u00e7) seviyelerini izleyin<\/li>\n<li><strong>Sekt\u00f6rler aras\u0131nda \u00e7e\u015fitlendirin<\/strong>: D\u00fczenleyici riskleri y\u00f6netmek i\u00e7in ila\u00e7 sekt\u00f6r\u00fcndeki pozisyonunuzu di\u011fer sekt\u00f6rlerle dengeleyin<\/li>\n<\/ol>\n<p><em>Mizahi deneyimli t\u00fcccar g\u00f6r\u00fc\u015f\u00fc: &#8220;\u0130la\u00e7 hisseleriyle ticaret yapmak fl\u00f6rt etmek gibidir &#8211; bazen harika kimya yakalars\u0131n\u0131z, bazen yan etkilerle kar\u015f\u0131la\u015f\u0131rs\u0131n\u0131z. Taahh\u00fctte bulunmadan \u00f6nce her zaman prospekt\u00fcs\u00fc okuyun!&#8221;<\/em><\/p>\n<h2>\u2705 Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform, hisse ticareti i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131za para yat\u0131r\u0131n<\/td>\n<td>Banka transferi, kredi kart\u0131 veya di\u011fer \u00f6deme y\u00f6ntemleriyle fon aktar\u0131m\u0131 yap\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Sipari\u015f vermeden \u00f6nce SNY&#8217;nin ger\u00e7ek zamanl\u0131 fiyat\u0131n\u0131 ve son haberleri kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015finizi verin<\/td>\n<td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n ve \u015firket haberlerini d\u00fczenli takip edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fc yeniden yat\u0131r\u0131m\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>SNY, temett\u00fcleri otomatik olarak yeniden yat\u0131rma imkan\u0131 sunar<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, Sanofi hisseleri ticareti konusunda birka\u00e7 avantaj sunmaktad\u0131r:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test etme imkan\u0131 sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>, tek bir belge ile an\u0131nda ticaret eri\u015fimi sunar. <strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri bulunmakta olup, yat\u0131r\u0131mc\u0131lara fon y\u00f6netiminde esneklik sa\u011flar.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, Sanofi gibi k\u00f6kl\u00fc \u015firketlerde pozisyon olu\u015fturmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir ve piyasa dinamiklerini pratik deneyimle \u00f6\u011frenmelerine olanak tan\u0131r.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Sanofi: Sa\u011fl\u0131kta Yenilik Lideri<\/h2>\n<p>Sanofi, \u00f6zellikle imm\u00fcnoloji, a\u015f\u0131lar ve nadir hastal\u0131klarda g\u00fc\u00e7l\u00fc olan k\u00fcresel bir sa\u011fl\u0131k lideridir. \u015eirketin stratejik oda\u011f\u0131, tek seferlik b\u00fcy\u00fck ba\u015far\u0131lar pe\u015finde ko\u015fmak yerine franchise seviyesinde i\u015f kollar\u0131 in\u015fa etmeye kaym\u0131\u015ft\u0131r.<\/p>\n<p>Son geli\u015fmeler aras\u0131nda, t\u00fcketici sa\u011fl\u0131\u011f\u0131 biriminin Opella i\u015flemiyle ba\u015far\u0131l\u0131 bir \u015fekilde ayr\u0131lmas\u0131 yer almakta olup, bu da daha odaklanm\u0131\u015f bir ila\u00e7 \u015firketi yaratm\u0131\u015ft\u0131r. \u00dcr\u00fcn hatt\u0131nda yakla\u015f\u0131k 30&#8217;u Faz 3 veya kay\u0131t a\u015famas\u0131nda olmak \u00fczere 82 klinik a\u015fama projesi bulunmaktad\u0131r (<a href=\"https:\/\/www.labiotech.eu\/in-depth\/sanofi-pipeline-2025\/\">Labiotech \u00dcr\u00fcn Hatt\u0131 Analizi<\/a>).<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Sanofi, TIME dergisi taraf\u0131ndan d\u00fcnyan\u0131n en s\u00fcrd\u00fcr\u00fclebilir onuncu \u015firketi ve \u0130la\u00e7 &amp; Biyoteknoloji sekt\u00f6r\u00fcnde birinci olarak s\u0131ralanm\u0131\u015f, \u00e7evresel ve sosyal sorumlulu\u011fa ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 ve t\u0131bbi yenili\u011fi te\u015fvik etme kararl\u0131l\u0131\u011f\u0131n\u0131 vurgulam\u0131\u015ft\u0131r.<\/p>\n"},"faq":[{"question":"Sanofi hisseleri nereden al\u0131nabilir?","answer":"Sanofi hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Sanofi hissesi i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ilen platforma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi baz\u0131 platformlarda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flanabilir."},{"question":"Sanofi'nin 2025 i\u00e7in fiyat tahmini nedir?","answer":"Analistler, Sanofi hisselerinin 2025 sonunda 55-58 $ aras\u0131nda i\u015flem g\u00f6rece\u011fini tahmin etmektedir."},{"question":"Sanofi hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc kontrol etmek, fiyat uyar\u0131lar\u0131 ayarlamak, piyasa haberlerini takip etmek ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"Sanofi'nin temel riskleri nelerdir?","answer":"D\u00fczenleyici bask\u0131lar, patent s\u00fcresi dolmalar\u0131, \u00c7in pazar\u0131ndaki zorluklar ve tedarik zinciri k\u0131r\u0131lganl\u0131klar\u0131 ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Sanofi hisseleri nereden al\u0131nabilir?","answer":"Sanofi hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Sanofi hissesi i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ilen platforma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi baz\u0131 platformlarda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flanabilir."},{"question":"Sanofi'nin 2025 i\u00e7in fiyat tahmini nedir?","answer":"Analistler, Sanofi hisselerinin 2025 sonunda 55-58 $ aras\u0131nda i\u015flem g\u00f6rece\u011fini tahmin etmektedir."},{"question":"Sanofi hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc kontrol etmek, fiyat uyar\u0131lar\u0131 ayarlamak, piyasa haberlerini takip etmek ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nemlidir."},{"question":"Sanofi'nin temel riskleri nelerdir?","answer":"D\u00fczenleyici bask\u0131lar, patent s\u00fcresi dolmalar\u0131, \u00c7in pazar\u0131ndaki zorluklar ve tedarik zinciri k\u0131r\u0131lganl\u0131klar\u0131 ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T18:21:04+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T18:21:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\"},\"wordCount\":16,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\",\"name\":\"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-25T18:21:04+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/","og_locale":"tr_TR","og_type":"article","og_title":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T18:21:04+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T18:21:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/"},"wordCount":16,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/","name":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-25T18:21:04+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-sanofi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Sanofi (SNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Sanofi (SNY) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":349771,"slug":"how-to-buy-sanofi","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Sanofi (SNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Sanofi (SNY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-sanofi\/"},"pt_AA":{"locale":"pt_AA","id":349763,"slug":"how-to-buy-sanofi","post_title":"Como comprar a\u00e7\u00f5es da Sanofi (SNY) - Investimento em a\u00e7\u00f5es da Sanofi (SNY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-sanofi\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=349778"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349778\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=349778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=349778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=349778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}